SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.61 CNY | -0.66% |
|
+1.14% | +8.38% |
| Apr. 16 | Shyndec Pharmaceutical's Unit Gets Nod to Market Empagliflozin Tablets | MT |
| Apr. 15 | China stocks rise after new guidelines; HK shares drop | RE |
Chart calendar Shanghai Shyndec Pharmaceutical Co., Ltd.
87984ac2ff2fbaaadfe9f1d.NqTa4XG69R1Ciq3iyLnerywvgBr4pPxkm05PuGxzxEw.BNforDLtnHQlzJvQgMGnm0tpy2uhwLYU0yp4y1wBkjlbkpSNFOzFRHHs9A~9f88954fb511deaf211c562c35a4f66a
Upcoming events on Shanghai Shyndec Pharmaceutical Co., Ltd.
Past events on Shanghai Shyndec Pharmaceutical Co., Ltd.
| 2024-03-29 | Q4 2023 Earnings Release |
| 2023-10-27 | Q3 2023 Earnings Release |
| 2023-09-13 02:00 am | Extraordinary Shareholders Meeting |
| 2023-08-28 | Q2 2023 Earnings Release |
| 2023-07-14 02:00 am | Extraordinary Shareholders Meeting |
| 2023-05-19 01:30 am | Annual General Meeting |
| 2023-04-28 | Q1 2023 Earnings Release |
| 2023-03-29 | Q4 2022 Earnings Release |
| 2022-11-28 01:00 am | Extraordinary Shareholders Meeting |
| 2022-10-27 | Q3 2022 Earnings Release |
| 2022-08-30 | Interim 2022 Earnings Release |
| 2022-07-21 02:00 am | Extraordinary Shareholders Meeting |
| 2022-06-27 10:00 pm | Annual General Meeting |
| 2022-04-29 | Q1 2022 Earnings Release |
| 2022-03-25 | FY 2021 Earnings Release |
| 2021-10-27 | Q3 2021 Earnings Release |
| 2021-08-27 | Interim 2021 Earnings Release |
| 2021-04-28 | Q1 2021 Earnings Release |
| 2021-04-28 01:30 am | Annual General Meeting |
| 2021-03-25 | FY 2020 Earnings Release |
Past dividends on Shanghai Shyndec Pharmaceutical Co., Ltd.
| 2023-07-05 | Annual 0.1 CNY |
| 2022-07-28 | Annual 0.1 CNY |
| 2021-06-24 | Annual 0.1 CNY |
| 2020-06-23 | Annual 0.1 CNY |
| 2019-06-25 | Annual 0.1 CNY |
| 2018-06-13 | Annual 0.05 CNY |
| 2017-05-24 | Annual 0.26 CNY |
| 2016-06-23 | Annual 0.05 CNY |
| 2015-06-11 | Annual 0.2 CNY |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 0,00 | 12 070 12 139 -0.57% | 13 353 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBIT | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
Net income Million CNY | Released Forecast Spread | 627 | 692 708 -2.28% | 863 |
|
EPS CNY | Released Forecast Spread | 0,61 | 0,54 0,53 2.51% | 0,64 |
| Announcement Date | 13/01/23 | 29/03/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 2 908 2 977 -2.32% | 3 343 | 3 238 | 3 433 | 3 339 |
|
EPS CNY | Released Forecast Spread | 0,09 0,13 -30.77% | 0,10 | 0,15 | 0,21 | 0,19 |
| Announcement Date | 29/03/24 | - | - | - | - |
More events
Past sector events for Shanghai Shyndec Pharmaceutical Co., Ltd.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 600420 Stock
- Calendar Shanghai Shyndec Pharmaceutical Co., Ltd.
